Juan-Ribelles, Antonio
Bautista, Francisco
Cañete, Adela
Rubio-San-Simón, Alba
Alonso-Saladrigues, Anna
Hladun, Raquel
Rives, Susana
Dapena, Jose Luís
Fernández, Jose María
Lassaletta, Álvaro
Cruz, Ofelia
Ramírez-Villar, Gemma
Fuster, Jose Luís
de Heredia, Cristina Diaz
García-Ariza, Miguel
Quiroga, Eduardo
del Mar Andrés, María
Verdú-Amorós, Jaime
Molinés, Antonio
Herrero, Blanca
López, Mónica
Márquez, Catalina
Toboso, María
Lendínez, Frencisco
Sirvent, Jose Gómez
Tallón, María
Rodríguez, Guiomar
Acha, Tomás
Moreno, Lucas http://orcid.org/0000-0002-0708-1670
Fernández-Teijeiro, Ana
,
Funding for this research was provided by:
Fundación Científica Asociación Española Contra el Cáncer (CICPF18016FERN 2018)
Article History
Received: 9 February 2024
Accepted: 4 March 2024
First Online: 10 April 2024
Declarations
:
: A. Juan Ribelles has had a consulting/advisory role for Alexion and Bayer, has participated in educational activities organized by Eusa Pharma, Abbott, and Alexion, and has received travel expenses by Nestle and Alexion. F. Bautista has been a member of a data monitoring committee (DMC) in a clinical trial sponsored by Sanofi, had a consulting or advisory role for Bayer, Amgen, Roche Genentech, EusaPharma, and Eisai, and received honoraria from Servier for educational events (through his current affiliation). A. Cañete has had an advisory role for Norgine, Bayer, Roche, Eusa-Pharma, SERB, and participated in educational activities organized by Eusa Pharma and Norgine and received travel expenses from Eusa-pharma and Nestlé. A. Rubio-San Simon has had a advisory role for Eusa Pharma and Sanofi and has received travel expenses by Roche and Eusa Pharma. A. Alonso-Saladrigues (AAS): advisory boards (Novartis). S. Rives reports personal fees, honoraria from Novartis, Servier, Celgene/ Bristol Myers Squibb, Kite/ Gilead, and Amgen. Also reports being part of DMSB in clinical trial sponsored by Novartis and of a DMC in a clinical trial sponsored by Autolus. A. Lassaletta has had an advisory role for Jazz, Servier, and Alexion; has received travel expenses by Servier, and has participated in educational activities organized by Alexion. G. Ramírez-Villar has had an advisory role for Alexion, has received travel expenses by Nestlé and has participated in educational activities organized by Alexion. J.L.Fuster was a consultant/advisory member for Amgen, Jazz Pharmaceuticals, and Novartis, received honoraria from Amgen, Servier, Jazz Pharmaceuticals, Pfizer, and Novartis for speaking at symposia and support from Servier and Jazz Pharmaceuticals for attending symposia. C. Diaz-de-Heredia is a member of study steering committees for clinical trials sponsored by Novartis, had a consulting or advisory role for Novartis, Jazz Pharmaceuticals, Biotest and Vertex, has participated in educational activities organized by Novartis and Jazz Pharmaceuticals and received travel expenses from Jazz Pharmaceuticals and Novartis. J. Verdú-Amorós has received honoraria by Servier and received travel expenses by Servier and EusaPharma. A. Molinés has participated in educational activities organized by Servier receiving travel and accommodation expenses. L. Moreno has been member of data monitoring committees for clinical trials sponsored by Novartis, Actuate Therapeutics, Shionogi and Incyte; had a consulting role for Novartis, Norgine, Boehringer, Ymabs, Bayer, Abbvie, BMS and Shionogi; participated in educational activities organized by Bayer and Eusa Pharma and received travel expenses from Eusa Pharma. He is President Elect of SIOPEN (European neuroblastoma research cooperative group), an organization which receives royalties for the sales of dinutuximab beta. A. Fernández-Teijeiro has had an advisory role for AstraZeneca, SOBI, Takeda, Norgine, Clinigen, Bayer, Roche, MERCK SHARP & DOHME, Novartis and Takeda; participated in educational activities organized by Amgen, Eusa Pharma, Servier and Takeda and received travel expenses from Servier, Amgen and Gilead. The other authors declare no conflict of interest.
: All human studies had been approved by the appropriate ethics committee and had, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Parents and/or legal guardians of children and adult patients participating in these clinical trials gave their informed consent prior to their inclusion in the studies reported in this manuscript.